22-hydroxycholesterol has been researched along with clofibrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appel, R; Bass, NM; Bettencourt, J; Crumrine, D; Elias, PM; Feingold, KR; Friedman, M; Hanley, K; He, SS; Jiang, Y; Kömüves, LG; Min, K; Williams, ML | 1 |
| Chang, S; Choi, EH; Demerjian, M; Elias, PM; Feingold, KR; Man, MQ | 1 |
2 other study(ies) available for 22-hydroxycholesterol and clofibrate
| Article | Year |
|---|---|
Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators.
Topics: alpha-Linolenic Acid; Amnion; Animals; Cell Differentiation; Clofibrate; DNA-Binding Proteins; Farnesol; Female; Fetus; Hydroxycholesterols; Injections; Juvenile Hormones; Nuclear Proteins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sesquiterpenes; Skin; Skin Physiological Phenomena; Transcription Factors | 1999 |
Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.
Topics: Animals; Cell Differentiation; Cell Membrane Permeability; Cell Proliferation; Clobetasol; Clofibrate; DNA-Binding Proteins; Epidermis; Female; Glucocorticoids; Hydroxycholesterols; Keratinocytes; Liver X Receptors; Male; Mice; Mice, Hairless; Models, Animal; Orphan Nuclear Receptors; PPAR alpha; PPAR gamma; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones | 2009 |